
Biogen Inc (BIIB) Stock: Analyzing the Market Value
Biogen Inc (NASDAQ: BIIB) has a higher price-to-earnings ratio of 10.83x compared to its average ratio, The 36-month beta value for BIIB is at 0.13.
Biogen Inc (NASDAQ: BIIB) has a higher price-to-earnings ratio of 10.83x compared to its average ratio, The 36-month beta value for BIIB is at 0.13.
Biogen Inc (NASDAQ: BIIB) has experienced a rise in its stock price by 0.38 compared to its previous closing price of 118.89. However, the company
Biogen Inc (NASDAQ: BIIB)’s stock price has gone decline by -1.44 in comparison to its previous close of 116.98, however, the company has experienced a
Biogen Inc (NASDAQ: BIIB)’s stock price has plunge by 5.65relation to previous closing price of 114.05. Nevertheless, the company has seen a -8.25% plunge in
The stock price of Biogen Inc (NASDAQ: BIIB) has plunged by -0.54 when compared to previous closing price of 132.03, but the company has seen
Biogen Inc (NASDAQ: BIIB) has a higher price-to-earnings ratio of 12.45x compared to its average ratio, The 36-month beta value for BIIB is at 0.04.
The price-to-earnings ratio for Biogen Inc (NASDAQ: BIIB) is 12.65x, which is above its average ratio. Moreover, the 36-month beta value for BIIB is 0.03.
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.